Middle East Pharmaceutical Industries Company

Middle East Pharmaceutical Industries Companyverified

4016.SR

Price:

$118.6

Market Cap:

$2.37B

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central nervous, digestive, and musculoskeletal system medicines; urinary and reproductive system drugs; disinfectants; and various therapeutic medicines and preparations, including sexual system drugs, diabetes, cardiovascular drugs, anti-infective drugs, anti-parasitic drugs, pain relievers,...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2024-02-27

Stock Exchange

SAU

Ticker

4016.SR

The PE Ratio as of December 2025 (TTM) for Middle East Pharmaceutical Industries Company (4016.SR) is 24.40

According to Middle East Pharmaceutical Industries Company’s latest financial reports and current stock price. The company's current PE Ratio is 24.40. This represents a change of -34.79% compared to the average of 37.42 of the last 4 quarters.

Middle East Pharmaceutical Industries Company (4016.SR) Historical PE Ratio (quarterly & annually)

How has 4016.SR PE Ratio performed in the past?

The mean historical PE Ratio of Middle East Pharmaceutical Industries Company over the last ten years is 34.72. The current 24.40 PE Ratio has changed 6.93% with respect to the historical average. Over the past ten years (40 quarters), 4016.SR's PE Ratio was at its highest in in the September 2024 quarter at 181.01. The PE Ratio was at its lowest in in the March 2023 quarter at -1073.56.

Quarterly (TTM)
Annual

Average

34.72

Median

34.12

Minimum

29.28

Maximum

39.44

Middle East Pharmaceutical Industries Company (4016.SR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Middle East Pharmaceutical Industries Company PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 20.92%

Maximum Annual PE Ratio = 39.44

Minimum Annual Increase = -25.77%

Minimum Annual PE Ratio = 29.28

Quarterly (TTM)
Annual
YearPE RatioChange
202439.1620.92%
202332.39-9.69%
202235.8611.49%
202132.179.85%
202029.28-25.77%

Middle East Pharmaceutical Industries Company (4016.SR) Average PE Ratio

How has 4016.SR PE Ratio performed in the past?

The current PE Ratio of Middle East Pharmaceutical Industries Company (4016.SR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

35.80

5-year avg

33.77

10-year avg

34.72

Middle East Pharmaceutical Industries Company (4016.SR) PE Ratio vs. Peers

How is 4016.SR’s PE Ratio compared to its peers?

Middle East Pharmaceutical Industries Company’s PE Ratio is less than Saudi Pharmaceutical Industries and Medical Appliances Corporation (28.00), less than Almujtama Alraida Medical Co. (28.56), less than Scientific and Medical Equipment House Company (34.97), greater than Al-Dawaa Medical Services Company (12.35), less than Naba Alsaha Medical Services Company (25.26), greater than Ame Company For Medical Supplies (14.35), greater than Middle East Healthcare Company (8.71), less than Canadian General Medical Center Complex Company (90.14), greater than Qomel Co. (22.38), greater than Al-Modawat Specialized Medical Co. (8.97),

Build a custom stock screener for Middle East Pharmaceutical Industries Company (4016.SR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Middle East Pharmaceutical Industries Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Middle East Pharmaceutical Industries Company (4016.SR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Middle East Pharmaceutical Industries Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Middle East Pharmaceutical Industries Company's PE Ratio?

How is the PE Ratio calculated for Middle East Pharmaceutical Industries Company (4016.SR)?

What is the highest PE Ratio for Middle East Pharmaceutical Industries Company (4016.SR)?

What is the 3-year average PE Ratio for Middle East Pharmaceutical Industries Company (4016.SR)?

What is the 5-year average PE Ratio for Middle East Pharmaceutical Industries Company (4016.SR)?

How does the current PE Ratio for Middle East Pharmaceutical Industries Company (4016.SR) compare to its historical average?